Journal article
Semiautomatic Training Load Determination in Endurance Athletes
C Dausin, S Ruiz-Carmona, R De Bosscher, K Janssens, L Herbots, H Heidbuchel, P Hespel, V Cornelissen, R Willems, A La Gerche, G Claessen
Journal for the Measurement of Physical Behaviour | HUMAN KINETICS PUBL INC | Published : 2023
Open access
Abstract
Background: Despite endurance athletes recording their training data electronically, researchers in sports cardiology rely on questionnaires to quantify training load. This is due to the complexity of quantifying large numbers of training files. We aimed to develop a semiautomatic postprocessing tool to quantify training load in clinical studies. Methods: Training data were collected from two prospective athlete’s heart studies (Master Athlete’s Heart study and Prospective Athlete Heart study). Using in-house developed software, maximal heart rate (MaxHR) and training load were calculated from heart rate monitored during cumulative training sessions. The MaxHR in the lab was compared with th..
View full abstractGrants
Awarded by National Health and Medical Research Council
Funding Acknowledgements
[ "Dausin and Ruiz-Carmona are joint fi rst authors. La Gerche and Claessen are shared senior authors. Pro@Heart Consortium includes the following author groups: Department of Cardiology, Baker Heart and Diabetes Institute, Melbourne, Australia: Amy Mitchell, Maria Brosnan, and David Prior. Department of Cardiovascular Sciences, KU Leuven, Leuven, Belgium: Piet Claus, Kaatje Goetschalckx, Sofie fi e Van Soest, and Mathias Claeys. Department of Cardiology, University Hospitals Leuven, Leuven, Belgium: So fi e Van Soest and Mathias Claeys. Department of Cardiology, Hartcentrum, Jessa Ziekenhuis, Hasselt, Belgium: Olivier Ghekiere, Daisy Thijs, and Peter Vanvoorden and Dominique Hansen. REVAL/BIOMED, Hasselt University, Diepenbeek, Belgium: Bert Op'tEijnde. ' tEijnde. Department of Cardiovascular Sciences, University of Antwerp, Antwerp, Belgium: Caroline M. Van De Heyning, Paul Van Herck, Bernard Paelinck, HarounEl Addouli, Hielko Miljoen, Kasper Favere, Dorien Vermeulen, and Isabel Witvrouwen. Department of Cardiology, University Hospital Antwerp, Antwerp, Belgium: Caroline M. Van De Heyning, Bernard Paelinck, Hielko Miljoen, Kasper Favere, Dorien Vermeulen, and Isabel Witvrou-wen. Department of Radiology, University Hospitals Leuven, Leuven, Belgium: Steven Dymarkowski, Tom Dresselaers, and Jan Bogaert. Fac-ulty of Medicine and Life Sciences, Cardiology and Organ Systems, Hasselt University, Diepenbeek, Belgium: Dominique Hansen. Depart-ment of Cardiology, Algemeen Ziekenhuis Nikolaas, Sint-Niklaas, Bel-gium: Kristof Lefebvre. Centre for Heart Rhythm Disorders, University of Adelaide and Royal Adelaide Hospital, Adelaide, Australia: Adrian Elliott and Prashanthan Sanders. Department of Cardiology, Royal Melbourne Hospital, Melbourne, Australia: : Jonathan Kalman. Victor Chang Cardiac Research Institute, Darlinghurst, New South Wales, Australia: Diane Fatkin. Energy lab, Paal, Belgium: Wim Van Hoolst. During the start-up and execution of the Master@Heart trial, a project advisory committee was created with yearly meetings on the development and progress of the study. The committee included the following public partners: Cycling Vlaanderen, Sport en Keuringsartsen, Triathlon Vlaanderen, and Sport Vlaanderen. The authors would like to thank the staff members of all sites for helping conduct the Pro@Heart and Master@Heart studies. The author (s) disclosed receipt of the following fi nancial support for the research, authorship, and/or publication of this article: The Master@Heart trial is supported by a research grant by the Fund for Scientific fi c Research Flanders (FWO-TBM [T003717N] ) . The Pro@Heart is supported by an unrestricted research grant from Boston Scientific fi c Belgium and Abbott Belgium and a research grant by KOOR from UZ Leuven and the National Health and Medical Research Council of Australia (APP1130353) . Will-ems is supported as postdoctoral clinical researcher by the Fund for Scientific fi c Research Flanders. Willems reports research funding from Abbott, Biotronik, Boston Scientific, fi c, and Medtronic; speakers and con-sultancy fees from Medtronic, Boston Scientific, fi c, Biotronik, and Abbott.r El Addouli, Hielko Miljoen, Kasper Favere, Dorien Vermeulen, and Isabel Witvrouwen. Department of Cardiology, University Hospital Antwerp, Antwerp, Belgium: Caroline M. Van De Heyning, Bernard Paelinck, Hielko Miljoen, Kasper Favere, Dorien Vermeulen, and Isabel Witvrou-wen. Department of Radiology, University Hospitals Leuven, Leuven, Belgium: Steven Dymarkowski, Tom Dresselaers, and Jan Bogaert.", "Fac-ulty of Medicine and Life Sciences, Cardiology and Organ Systems, Hasselt University, Diepenbeek, Belgium: Dominique Hansen. Depart-ment of Cardiology, Algemeen Ziekenhuis Nikolaas, Sint-Niklaas, Bel-gium: Kristof Lefebvre. Centre for Heart Rhythm Disorders, University of Adelaide and Royal Adelaide Hospital, Adelaide, Australia: Adrian Elliott and Prashanthan Sanders. Department of Cardiology, Royal Melbourne Hospital, Melbourne, Australia: : Jonathan Kalman. Victor Chang Cardiac Research Institute, Darlinghurst, New South Wales, Australia: Diane Fatkin. Energy lab, Paal, Belgium: Wim Van Hoolst. During the start-up and execution of the Master@Heart trial, a project advisory committee was created with yearly meetings on the development and progress of the study. The committee included the following public partners: Cycling Vlaanderen, Sport en Keuringsartsen, Triathlon Vlaanderen, and Sport Vlaanderen. The authors would like to thank the staff members of all sites for helping conduct the Pro@Heart and Master@Heart studies. The author (s) disclosed receipt of the following fi nancial support for the research, authorship, and/or publication of this article: The Master@Heart trial is supported by a research grant by the Fund for Scientific fi c Research Flanders (FWO-TBM [T003717N] ) . The Pro@Heart is supported by an unrestricted research grant from Boston Scientific fi c Belgium and Abbott Belgium and a research grant by KOOR from UZ Leuven and the National Health and Medical Research Council of Australia (APP1130353) . Will-ems is supported as postdoctoral clinical researcher by the Fund for Scientific fi c Research Flanders. Willems reports research funding from Abbott, Biotronik, Boston Scientific, fi c, and Medtronic; speakers and con-sultancy fees from Medtronic, Boston Scientific, fi c, Biotronik, and Abbott." ]